Sensyne interims ‘disappointing’ but position group for future growth

Sensyne Health said its latest interim results were disappointing after revenue more than halved to £1min the six months ended 31 October 2021. The clinical AI company, which announced the completion of a £11.4m fundraise on 26 January, said it had been a challenging period, which ‘tested the commitment and resilience’ of the group, its staff and stakeholders. Revenue primarily derived…